3

Initial Statement of Ownership

Travere Therapeutics, Inc. Filed 2022-09-01 Acc 0001209191-22-048342

Documents 1

3 Initial Statement of Ownership , xslF345X02/doc3.xml

Around this filing

2022-09-01 4 Chief Financial Officer acquired 5,000 shares (grant or award)
2022-09-01 3 Initial Statement of Ownership
2022-01-04 3 Initial Statement of Ownership

Link to a passage

External

SEC EDGAR (opens in new tab)